Biogen Pharmachem Industries Ltd - Stock Valuation and Financial Performance

BSE: 531752 | NSE: | Trading | Small Cap

Biogen Pharmachem Share Price

1.14 0.00 0.00%
as on 26-Apr'24 16:00

DeciZen - make an informed investing decision on Biogen Pharmachem

M-Cap below 100cr DeciZen not available

Biogen Pharmachem Industries stock performance -

mw4me loader
P/E Ratio (SA):
75.00
Market Cap:
74.4 Cr.
52-wk low:
0.6
52-wk high:
1.9

Is Biogen Pharmachem Industries Ltd an attractive stock to invest in?

1. Is Biogen Pharmachem Industries Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Biogen Pharmachem Industries Ltd is a below average quality company.

2. Is Biogen Pharmachem Industries Ltd undervalued or overvalued?

The key valuation ratios of Biogen Pharmachem Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Biogen Pharmachem Industries Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Biogen Pharmachem Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Biogen Pharmachem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Biogen Pharmachem Industries Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % -0.1%-0.1%-0%-0.2%-3.3%-0%-0.2%-0.9%0.4%-0%-
Value Creation
Index
-1.0-1.0-1.0-1.0-1.2-1.0-1.0-1.1-1.0-1.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00000101.62.500
Sales YoY Gr.-NANANANANA-100%NA52.5%-100%-
Adj EPS 0000-000-0000
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 0.90.90.90.90.80.80.90.80.80.80.9
Adj Net
Profit
-0.1-0.10-0.1-1.90-0.1-0.50.201
Cash Flow from Ops. 0.1-7.34.7-0.1-13.70.1-1.241.41.7-
Debt/CF from Ops. 1025.2-1.41.3-10.807.2-0.3000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA-100%
Adj EPS NANANANA
BVPS-1.2%0.2%-0.4%1.2%
Share Price 17.9% 37.7% 68.1% 72.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
-0.2-0.2-0.1-0.2-3.3-0-0.2-0.90.4-02.4
Op. Profit
Mgn %
00000-0.400.3120NAN
Net Profit
Mgn %
00000-0.40-29.48.50INF
Debt to
Equity
0.90.20.10000000-
Working Cap
Days
0000019,937010,6176,83500
Cash Conv.
Cycle
000002,68301,18118200

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 2.40%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Biogen Pharmachem Industries Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 0.9 -
Reserves (₹ Cr.) -9 -
P/BV 1.33 -
PE 75.00 -
From the Market
52 Week Low / High (₹) 0.62 / 1.85
All Time Low / High (₹) 0.02 / 18.70
Market Cap (₹ Cr.) 74.4
Equity (₹ Cr.) 65.3
Face Value (₹) 1
Industry PE 77.6

Management X-Ray of Biogen Pharmachem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Biogen Pharmachem

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales000000.9501.622.470
Operating Expenses 0.130.140.030.126.720.950.123.232.490.46
Manufacturing Costs0000000000
Material Costs000000.9101.482.010
Employee Cost 0000.010.030.040.040.010.050.17
Other Costs 0.130.130.030.116.690.010.081.730.420.28
Operating Profit -0.13-0.14-0.03-0.12-6.720-0.12-1.60-0.02-0.46
Operating Profit Margin (%) ------0.4%--98.8%-0.6%-
Other Income 00000.150000.010.91
Interest 0000000000
Depreciation 0000000000
Exceptional Items 0000000000
Profit Before Tax -0.13-0.13-0.03-0.12-6.560-0.12-1.60-0.010.46
Tax 0000000000
Profit After Tax -0.13-0.13-0.03-0.12-6.560-0.12-1.60-0.010.46
PAT Margin (%) ------0.4%--98.8%-0.3%-
Adjusted EPS (₹)0.00.00.00.0-0.10.00.00.00.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 61.1260.9960.9660.8454.2854.2755.7554.1454.1354.59
Share Capital 65.2665.2665.2665.2665.2665.2665.2665.2665.2665.26
Reserves -4.14-4.27-4.30-4.42-10.98-10.99-9.51-11.12-11.13-10.67
Minority Interest0000000000
Debt57.21106.210.720.010.630.31000
Long Term Debt07.666.210.720.010.630.31000
Short Term Debt57.212.3400000000
Trade Payables3.210.860001.0900.0600
Others Liabilities 1.731.641.641.691.641.640.040.050.820.24
Total Liabilities 123.2673.4968.8163.2555.9357.6356.0954.2554.9554.83

Fixed Assets

Gross Block0000000000
Accumulated Depreciation0000000000
Net Fixed Assets0000000000
CWIP 0000000000
Investments 60.8643.7826.6922.393.526.256.459.496.958.85
Inventories0000000000
Trade Receivables0.870.86007.038.038.032.5400
Cash Equivalents 1.490.100.130.060.02000.010.080.13
Others Assets60.0528.7541.9840.7945.3643.3541.6242.2147.9145.85
Total Assets 123.2673.4968.8163.2555.9357.6356.0954.2554.9554.83

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 0.06-7.284.68-0.07-13.650.09-1.213.951.401.70
PBT -0.13-0.13-0.03-0.12-6.560-0.12-1.60-0.010.46
Adjustment 0000000000
Changes in Working Capital 0.19-7.144.710.05-7.080.09-1.15.551.411.25
Tax Paid 0000000000
Cash Flow From Investing Activity -8.9917.0817.084.3014.32-0.721.54-3.64-1.32-1.66
Capex 0000000000
Net Investments -8.9917.0817.084.3018.88-2.73-0.20-3.042.54-1.90
Others 0000-4.562.011.74-0.60-3.860.24
Cash Flow From Financing Activity 10.33-11.19-21.74-4.31-0.710.62-0.32-0.3100
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 06.94-1.451.18000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 10.33-18.13-20.29-5.49-0.710.62-0.32-0.3100
Net Cash Flow 1.39-1.380.02-0.07-0.03-0.02000.080.05
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-0.21-0.22-0.05-0.2-11.4-0.01-0.21-2.92-0.020.84
ROCE (%)-0.14-0.14-0.04-0.19-11.33-0.01-0.21-2.91-0.020.84
Asset Turnover Ratio000000.0200.030.050
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/A3.7
Working Capital Days
Receivable Days000002,89301,18800
Inventory Days0000000000
Payable Days0000021901500

Biogen Pharmachem Industries Ltd Stock News

Biogen Pharmachem Industries Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Biogen Pharmachem on 26-Apr-2024 16:00 is ₹1.14.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 26-Apr-2024 16:00 the market cap of Biogen Pharmachem stood at ₹74.40.
The latest P/E ratio of Biogen Pharmachem as of 26-Apr-2024 16:00 is 75.00.
The latest P/B ratio of Biogen Pharmachem as of 26-Apr-2024 16:00 is 1.33.
The 52-week high of Biogen Pharmachem is ₹1.85 and the 52-week low is ₹0.62.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biogen Pharmachem is ₹0.00 ( Cr.) .

About Biogen Pharmachem Industries Ltd

Sun Techno Overseas Ltd., formerly Wellworth Overseas Limited, is an India-based company.In 2011 the company changed its name from Wellworth Overseas Ltd. to Sun Techno Overseas Ltd.

The company is engaged in the business of trading in shares and securities, small level of stock broking and consulting works. As of March 31, 2009, the company had started trading operations and business in commodities, both in agro-based and precious metals, and other goods in present and future markets.

The company is also diversifying its business activities in the power sector, by establishing wind power generation plant.

Read More Read Less
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.